Umeclidinium bromide/vilanterol

Umeclidinium bromide/vilanterol, sold under the brand name Anoro Ellipta, among others, is a fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD).^[5][6] It is administered by inhalation.

Umeclidinium bromideMuscarinic antagonist

VilanterolUltra-long-acting β₂ agonist

Trade namesAnoro Ellipta, others

AHFS/Drugs.comProfessional Drug Facts

Quick facts Combination of, Vilanterol ...

Umeclidinium bromide/vilanterol

Umeclidinium bromide (TOP), vilanterol (BOTTOM)
Combination of
Umeclidinium bromide	Muscarinic antagonist
Vilanterol	Ultra-long-acting β2 agonist
Clinical data
Trade names	Anoro Ellipta, others
AHFS/Drugs.com	Professional Drug Facts
License data	US DailyMed: Anoro
Pregnancy category	AU: B3
Routes of administration	Inhalation
ATC code	R03AL03 (WHO)
Legal status
Legal status	AU: S4 (Prescription only)[1] UK: POM (Prescription only)[2] US: ℞-only[3] EU: Rx-only[4]
Identifiers
CAS Number	2446159-58-4
KEGG	D10533

Close

The most common side effects include upper respiratory tract infections, urinary tract infections, pharyngitis, sinusitis, nasopharyngitis, headache, cough, oropharyngeal pain, constipation and dry mouth.^[4]

In 2022, it was the 211th most commonly prescribed medication in the United States, with more than 1 million prescriptions.^[7][8]